HFRO (HFRO) Stock Price & Analysis
HFRO (HFRO) rose 4.65% to USD 6.98 as of June 10, 2026 at 05:35 UTC, according to Nexqual real-time market data.
HFRO last closed at USD 6.67; the session ranged USD 6.79–6.99 on volume of 440,311 shares. Market capitalization is $386.74M, with a 52-week range of USD 5.03–6.99 (NYQ). Source: Nexqual, June 10, 2026 at 05:35 UTC.
Key Statistics (as of June 10, 2026 at 05:35 UTC)
| Price | USD 6.98 |
|---|---|
| Change | ▲ 4.65% (up) |
| Previous Close | USD 6.67 |
| Open | USD 6.73 |
| Day Range | USD 6.79 – 6.99 |
| 52-Week Range | USD 5.03 – 6.99 |
| Volume | 440,311 shares |
| Market Cap | $386.74M |
| Exchange | NYQ |
Technical Analysis (HFRO)
Nexqual's technical model rates HFRO "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 05:35 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 66.56 (neutral) |
| vs SMA50 | Above (USD 6.13) |
| MACD | 0.16 (positive) |
Analyst Ratings (HFRO)
Wall Street analysts rate HFRO "None", per Nexqual as of June 10, 2026 at 05:35 UTC.
| Consensus Rating | None |
|---|
Earnings (HFRO)
Source: Nexqual, June 10, 2026 at 05:35 UTC.
Financials & Fundamentals (HFRO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 05:35 UTC.
Financial Health Score (HFRO)
Nexqual rates HFRO's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:35 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (HFRO)
| Insider Ownership | +3.77% |
|---|---|
| Institutional Ownership | +89.02% |
| Shares Outstanding | 55.41M |
| Short % of Float | +0.04% |
Source: Nexqual, June 10, 2026 at 05:35 UTC.
Major Backers & Investors (HFRO)
Notable institutional backers of HFRO include Saba Capital Management, L.P., Nexpoint Asset Management, L.P., Raymond James Financial, Inc., according to Nexqual as of June 10, 2026 at 05:35 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 9.29% |
| Nexpoint Asset Management, L.P. | 7.45% |
| Raymond James Financial, Inc. | 7.08% |
| Invesco | 5.17% |
| Herzfeld (Thomas J.) Advisors, Inc | 4.9% |
| Highland Global Allocation Fund | 4.76% |
| Morgan Stanley | 4.59% |
| Envestnet Asset Management Inc. | 3.88% |
Source: Nexqual, June 10, 2026 at 05:35 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HGLB | Highland Global Allocation Fund | USD 7.68 | ▼ 1.41% |
| XFLT | XAI Octagon Floating Rate & Alt | USD 18.15 | ▲ 0.46% |
| THW | Tekla World Healthcare Fund Sha | USD 12.17 | ▼ 2.17% |
| DFP | Flaherty & Crumrine Dynamic Pre | USD 20.25 | ▲ 0.5% |
| ARDC | Ares Dynamic Credit Allocation | USD 12.52 | ▲ 0.16% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:35 UTC. This page is informational and not investment advice.